malignant biliary stricture (MBS)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) patients with inoperable distal malignant biliary strictures 2) patients with malignant biliary strictur comfirmed histopathologically 3) patients with proximal border of malignant biliary stricture thatis far from hilar at least 2cm away
Exclusion criteria
Exclusion criteria: 1) Coagulopathy (PT-INR > 1.5, normal 0.85-1.25 or platelet count < 80,000/mm3, normal 150,000-450,000/mm3) 2) Performance status < 3 (scales of the Eastern Cooperative Oncology Group)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stent patency | — |
Secondary
| Measure | Time frame |
|---|---|
| The rates of technical and clinical success | — |
Countries
Asia(except Japan)
Contacts
Digestive Disease Center and Research Institute, Department of Internal Medicine, Gastroenterology